Subscribe free

Intestine and Lower Gastrointestinal Tract ·

Prediction models for disease-free survival in colon cancer

A prospective study developed and validated pre- and post-operative models for predicting disease-free survival (DFS) after curative right-sided hemicolectomy in colorectal cancer patients. The study tracked 822 patients, revealing 1, 3, and 5-year DFS rates of 85.6%, 72.5%, and 57.6%, respectively. Key risk factors for recurrence included increasing age, male gender, and advanced disease stage. The models, with c-index values of 0.75 and 0.78, aim to enhance risk stratification and treatment decisions.

Journal Article by Lucocq J, Trinder T (…) Muthukumarasamy G et 3 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

All papers in Intestine and Lower Gastrointestinal Tract →